Ana Matilla
0000-0002-6586-2440
Publication & Citation Trends
Publications
0 total
Quality of life in patients with unresectable hepatocellular carcinoma treated with selective internal radiation therapy (SIRT) and Nivolumab: a sub-analysis of the NASIR-HCC trial
Cited by 0
Semantic Scholar
Surgical resection of hepatocellular carcinoma has high feasibility, safety and survival in non-cirrhotic liver: a prospective Spanish multicentre study
Cited by 0
Semantic Scholar
Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: a prospective case series
Cited by 1
Semantic Scholar
The complex management of hepatocellular carcinoma: a major need of expertise. OA
Cited by 0
Semantic Scholar
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial OA
Cited by 55
Semantic Scholar
CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma OA
Cited by 18
Semantic Scholar
Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history OA
Cited by 13
Semantic Scholar
SO-12 Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients with advanced hepatocellular carcinoma (aHCC): 5-year results from CheckMate 040 OA
Cited by 3
Semantic Scholar
Research Topics
Hepatocellular Carcinoma Treatment and Prognosis
(48)
Liver Disease Diagnosis and Treatment
(36)
Liver Disease and Transplantation
(24)
Cancer Immunotherapy and Biomarkers
(19)
Hepatitis C virus research
(12)
Affiliations
Universidad Complutense de Madrid
Hospital General Universitario Gregorio Marañón
University of Colorado Health
Hospital Universitario 12 De Octubre
Hospital Universitario Príncipe de Asturias